NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









enParticle

Private
BusanHealthcare & Life Sciences

Last Round

Debt

Dec 1, 2022

Total Funding Raised

$5.63M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

enParticle is a drug delivery company that has developed a microfluidic formulation system designed for scalable and reproducible production of particles for the pharmaceutical, cosmetic, and food industries.

Sector

Healthcare & Life Sciences

Verticals

Biotech Equipment, Biotechnology, Precision Medicine, Smart Manufacturing

Business Model

B2B

Customer Profile

Services & Consulting, Hardware Sales

AI Layer

Non-AI

Keywords

lipid nanoparticlesLNPmicrofluidic technologyCDMOCMOnanoparticle formulationLNP manufacturingbiotech equipmentparticle scale-updrug deliveryformulation servicescontract development and manufacturing organizationcontract manufacturing organizationparticle manufacturingliposomesdisposable microfluidic cartridgesadvanced materials

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

enParticle Comparables

Compare enParticle with similar companies based on industry and business-model similarity.

enParticle comparables — related companies by embedding similarity
CompanySimilarityMarket Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

enParticle Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
DebtDec 1, 2022
Series AAug 1, 2022
StrategicApr 8, 2022
GrantJun 1, 2019
SeedApr 8, 2019
Seed
Feb 12, 2019

enParticle Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 15, 2026

    Monthly visitors increased 223% MoM.

  • Mar 4, 2026

    Monthly visitors grew 283% MoM.

enParticle Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

enParticle Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about enParticle's valuation, stock price, and market status.

Firmographic Details

HeadquartersBusan
Employee Range2
Year Founded2019
Last FundingDec 1, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.